TD Cowen Upgrades UnitedHealth Group to Buy; Investor Probe Notice Also Issued
· 3 sources
TD Cowen raised its UnitedHealth Group (UNH) rating to Buy, citing the earnings outlook, while SueWallSt announced a pending investigation into the company.
What happened
TD Cowen has upgraded UnitedHealth Group (UNH) to a Buy rating, according to StreetInsider and Investing.com. Investing.com links the rating change to the company's earnings outlook.
Separately, PR Newswire carried a notice in which SueWallSt told investors about a pending investigation into UnitedHealth Group. The headline does not give further details on the scope or basis of that investigation.
The sources reviewed by ATLAS do not include additional details on the upgrade, such as a price target or the analyst's full reasoning.
Context
Brokerage rating changes reflect an analyst's view of a company's prospects, and investor-rights firms often announce inquiries into publicly traded companies.
Why it matters
An analyst upgrade and a notice of an investigation point in different directions, so both may be followed by investors watching UnitedHealth Group.
Stocks in this story
Price changes are shown for the trading day of the story and are a coincidence in time, not proof that the news caused them. Figures are ATLAS data from our database.
$395.01Fair range: $355.51 to $434.51The price ($330.48) is 16.3% below that figure.
Chance of a rise in 1 month
49%Probability of closing higher than today within 21 sessions.Normal range: half of the scenarios end between $301.69 and $358.65; 9 in 10, between $258.81 and $418.07.
Fair value, probabilities and earnings for every stock. Free account, no card. Information, not advice.
Information, not advice. This content is informational and is not an investment recommendation or an offer to buy or sell securities. ATLAS estimates come from statistical models using public data, can be wrong, and past performance does not guarantee future results. Disclaimer
ATLAS Signals
ATLAS Signals, every week
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy